Jiangsu Apon Medical Technology Co Ltd Class A (300753) — Net Asset Quality Index
Jiangsu Apon Medical Technology Co Ltd Class A (300753) has a Net Asset Quality Index of 81.7% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥839.64 Million minus total liabilities of CN¥153.56 Million yields net assets of CN¥686.08 Million. A higher index indicates a stronger, lower-leverage balance sheet. See Jiangsu Apon Medical Technology Co Ltd C defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Jiangsu Apon Medical Technology Co Ltd Class A Net Asset Quality Index Over Time (2014–2024)
This chart shows how Jiangsu Apon Medical Technology Co Ltd Class A's Net Asset Quality Index has evolved across 11 annual periods from 2014 to 2024. As of September 2025, the index stands at 81.7%, representing net assets of CN¥686.08 Million against total assets of CN¥839.64 Million CNY. Explore Jiangsu Apon Medical Technology Co Ltd C operating cash flow efficiency to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Jiangsu Apon Medical Technology Co Ltd Class A (2014–2024)
The table below presents the year-by-year Net Asset Quality Index for Jiangsu Apon Medical Technology Co Ltd Class A from 2014 to 2024, covering 11 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see 300753 market cap.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 82.0% | CN¥707.86 Million | CN¥863.49 Million | CN¥155.62 Million | ▲ +0.9 pp |
| 2023 | 81.1% | CN¥697.20 Million | CN¥859.57 Million | CN¥162.38 Million | ▲ +2.2 pp |
| 2022 | 78.9% | CN¥686.36 Million | CN¥870.21 Million | CN¥183.85 Million | ▼ -7.9 pp |
| 2021 | 86.8% | CN¥780.52 Million | CN¥899.06 Million | CN¥118.54 Million | ▼ -2.6 pp |
| 2020 | 89.4% | CN¥739.84 Million | CN¥827.24 Million | CN¥87.40 Million | ▲ +0.4 pp |
| 2019 | 89.1% | CN¥674.88 Million | CN¥757.64 Million | CN¥82.76 Million | ▼ -0.1 pp |
| 2018 | 89.2% | CN¥613.39 Million | CN¥687.96 Million | CN¥74.56 Million | ▲ +5.3 pp |
| 2017 | 83.8% | CN¥279.38 Million | CN¥333.26 Million | CN¥53.87 Million | ▲ +5.9 pp |
| 2016 | 78.0% | CN¥229.59 Million | CN¥294.51 Million | CN¥64.92 Million | ▼ -2.7 pp |
| 2015 | 80.7% | CN¥145.40 Million | CN¥180.28 Million | CN¥34.88 Million | ▲ +10.4 pp |
| 2014 | 70.3% | CN¥81.37 Million | CN¥115.80 Million | CN¥34.43 Million | — |